| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/07/2010 | WO2010002478A2 Glycopeptide and uses thereof |
| 01/07/2010 | WO2010002367A1 Diagnostic markers of breast cancer treatment and progression and methods of use thereof |
| 01/07/2010 | WO2010002356A1 Methods for predicting tumor response to chemotherapy and selection of tumor treatment |
| 01/07/2010 | WO2010002251A1 Vaccine against amyloid folding intermediate |
| 01/07/2010 | WO2010002123A2 Medical urinal for autodiagnosis |
| 01/07/2010 | WO2010002097A1 Apparatus for testing urine |
| 01/07/2010 | WO2010002024A1 Process for analyzing low molecular weight organic compound having at most 20 carbon atoms in cloth made of chemical fibers treated with water and oil repellent agent |
| 01/07/2010 | WO2010001924A1 Method and specimen for detecting sensitivity to isoniazid in tubercle bacillus |
| 01/07/2010 | WO2010001923A1 Method and specimen for detecting sensitivity to isoniazid in tubercle bacillus |
| 01/07/2010 | WO2010001908A1 Anti-cd27 antibody |
| 01/07/2010 | WO2010001902A1 Oligonucleotide probe, and use thereof |
| 01/07/2010 | WO2010001891A1 Antibody complex, antigen detection method, and method for production of antibody complex |
| 01/07/2010 | WO2010001876A1 Biochip substratum and method for production thereof |
| 01/07/2010 | WO2010001636A1 Dna array |
| 01/07/2010 | WO2010001619A1 Method for enhancing sensitivity or method for avoiding influence of hemoglobin in immunological measurement |
| 01/07/2010 | WO2010001617A1 Use of an efficacy marker for optimizing therapeutic efficacy of an anti-human pd-1 antibody on cancers |
| 01/07/2010 | WO2010001600A1 Positive affect marker gene and use thereof |
| 01/07/2010 | WO2010001598A1 Porous solid phase for binding assay, and binding assay method using the same |
| 01/07/2010 | WO2010001585A1 Anti-cdh3 antibodies labeled with radioisotope label and uses thereof |
| 01/07/2010 | WO2010001432A1 System (best-integrated toxicity (bio) sensor's system for hazard analysis and management in the food chain and the environment) for environment diagnostic and monitoring and self-control of food chain, including primary production, and relevant method for quick management of hazard |
| 01/07/2010 | WO2010001395A2 Detection of trinitrotoluene |
| 01/07/2010 | WO2010001375A1 Primitive vascular progenitor cells and uses thereof |
| 01/07/2010 | WO2010001298A1 Chemical sensors modified by the sol-gel method and its application to polymeric matrixes |
| 01/07/2010 | WO2010001254A2 Method and apparatus for sorting cells |
| 01/07/2010 | WO2010001219A1 Method for measuring activated factor vii level in a sample |
| 01/07/2010 | WO2010001211A1 Method for performing a test for infectious deseases on body fluids |
| 01/07/2010 | WO2010001175A1 Modified cells and methods of monitoring their viability |
| 01/07/2010 | WO2010001162A1 Freeze-dried compositions for biochemical reactions |
| 01/07/2010 | WO2010001131A1 Detection of interactions between lipid complexes and lipid binding agents |
| 01/07/2010 | WO2010001089A1 Structural determination apparatus and method |
| 01/07/2010 | WO2010001074A2 Novel detection probe |
| 01/07/2010 | WO2010000956A1 Use of carbon nanomaterials as a filtration material impervious to ozone |
| 01/07/2010 | WO2010000907A1 Genomic fingerprint of mammary cancer |
| 01/07/2010 | WO2010000874A2 Marker sequences for inflammatory prostate diseases, prostate carcinoma and their use |
| 01/07/2010 | WO2010000854A2 New bacteriophage adhesion proteins |
| 01/07/2010 | WO2010000849A2 A method for the screening of conserved secreted proteins |
| 01/07/2010 | WO2010000835A1 Proteomic fingerprint for the diagnosis of non-alcoholic steatohepatitis (nash) and/or steatosis |
| 01/07/2010 | WO2010000820A2 Copd diagnosis |
| 01/07/2010 | WO2010000819A1 Cellular copd diagnosis |
| 01/07/2010 | WO2010000756A1 Detection of shed cd31, diagnosis of atherothrombosis and autoimmune disorders, and methods for analyzing signaling pathways |
| 01/07/2010 | WO2010000593A1 Biochips for detecting the enzymatic activity of a protease enzyme |
| 01/07/2010 | WO2010000591A2 Fluorescent cyclic peptides, methods for the preparation thereof, and use of said peptides for measuring the enzymatic activity of a protease enzyme |
| 01/07/2010 | WO2010000574A2 Device for generating wide spectral band laser pulses, particularly for a tomographic atom probe |
| 01/07/2010 | WO2010000493A2 Inorganic-binding peptides and quality control methods using them |
| 01/07/2010 | WO2010000467A1 Asc as a marker for lung cancer |
| 01/07/2010 | WO2010000415A1 Isolation and/or identification of stem cells having adipocytic, chondrocytic and pancreatic differentiation potential |
| 01/07/2010 | WO2010000219A1 Capacitively operating sensor unit for monitoring the quality of fiber material and machine equipped therewith for producing knitted fabrics |
| 01/07/2010 | WO2010000218A1 Capacitive action sensor unit for monitoring the quality of fibre material and machine for producing knitted goods provided therewith |
| 01/07/2010 | WO2010000098A1 A food and health analysis system and an analysis method |
| 01/07/2010 | WO2010000089A1 Stat3 and tyk2 as drug targets for neurodegenerative diseases |
| 01/07/2010 | WO2010000055A1 Method and apparatus for on-site drilling cuttings analysis |
| 01/07/2010 | WO2010000054A1 Dynamic light scattering for in vitro testing of bodily fluids |
| 01/07/2010 | WO2010000012A1 Method for preventing transport of a neurotropic virus |
| 01/07/2010 | WO2009140679A3 Genetic alterations on chromosomes 21q, 6q and 15q and methods of use thereof for the diagnosis and treatment of type i diabetes |
| 01/07/2010 | WO2009140452A3 Isolation of stem cell precursors and expansion in non-adherent conditions |
| 01/07/2010 | WO2009140374A3 Inactivatable target capture oligomers for use in the selective hybridization and capture of target nucleic acid sequences |
| 01/07/2010 | WO2009139928A3 Recombinant chimeric antigens for diagnosis and prevention of scrub typhus |
| 01/07/2010 | WO2009138767A3 Chemical screening |
| 01/07/2010 | WO2009138250A3 Identification of ligand recognition domains |
| 01/07/2010 | WO2009134647A3 Apparatus and methods for performing photoreactions and analytical methods and devices to detect photo-reacting compounds |
| 01/07/2010 | WO2009132257A3 Cytological methods for detecting cancer |
| 01/07/2010 | WO2009132126A3 Method for predicting risk of metastasis |
| 01/07/2010 | WO2009131909A3 Recombinant deamidated gliadin antigen |
| 01/07/2010 | WO2009130176A9 Antiviral therapy |
| 01/07/2010 | WO2009128610A3 Cell labeling and imaging using multifunctional perfluorocarbon nanoemulsion |
| 01/07/2010 | WO2009126099A9 Device for storing a biological sample and for preparing the biological sample |
| 01/07/2010 | WO2009124258A3 Novel protein for binding bacillus thuringiensis cry toxins and fragments of cadherins for enhancing cry toxicity against dipterans |
| 01/07/2010 | WO2009124135A3 Annexin-based apoptosis markers |
| 01/07/2010 | WO2009123737A3 Advanced detection of sepsis |
| 01/07/2010 | WO2009121948A3 Single domain antibodies capable of modulating bace activity |
| 01/07/2010 | WO2009121043A3 Cotton thread as a low-cost multi-assay diagnostic platform |
| 01/07/2010 | WO2009120899A3 G coupled protein receptors associated with myelogenous haematological proliferative disorders and uses thereof |
| 01/07/2010 | WO2009120676A3 Method of characterizing and quantifying calcifying nanoparticles |
| 01/07/2010 | WO2009117517A3 Nanopore and carbon nanotube based dna sequencer |
| 01/07/2010 | WO2009117469A3 Examination device for blood detection |
| 01/07/2010 | WO2009117138A3 Counterstaining method for dual-stain in situ hybridization |
| 01/07/2010 | WO2009115756A3 Method for direct detection of ischaemia-modified albumin using a partner for binding to an aldehyde derivative resulting from the peroxidation of lipids in bound form |
| 01/07/2010 | WO2009114817A3 Pttg1 as a biomarker for cancer treatment |
| 01/07/2010 | WO2009111615A3 Systems for measuring properties of a physiological fluid suspension |
| 01/07/2010 | WO2009111461A3 Microfluidic flow cell |
| 01/07/2010 | WO2009103061A3 Methods and compositions for identifying, diagnosing, and treating neuroblastoma |
| 01/07/2010 | WO2009099590A3 Psoriatic phenotype mice, cell lines, treatments, and methods |
| 01/07/2010 | WO2009090267A3 Dye-doped nanoparticles, a method of manufacture of the same, and a method of determining a percentage weight of a dye which yields a required relative fluorescent intensity from a dye-doped nanoparticle |
| 01/07/2010 | WO2009086333A3 Methods and compositions relatin to antibodies that bind a protein reticulon 3 |
| 01/07/2010 | WO2009063226A3 Methods relating to breathing disorders |
| 01/07/2010 | WO2009059318A3 Genes and polymorphisms associated with amd |
| 01/07/2010 | WO2009055823A3 Method to predict responsiveness of breast cancer to polyaminetype chemotherapy |
| 01/07/2010 | WO2009024869A3 Methods and devices for controlled monolayer formation |
| 01/07/2010 | WO2008118831A8 Droplet actuator loading and target concentration |
| 01/07/2010 | WO2008102340A3 Kits and methods for determining colon cleanliness |
| 01/07/2010 | WO2005114190A3 Methods of identifying biomarkers |
| 01/07/2010 | US20100005047 Methods, Systems, and Software for Identifying Functional Bio-Molecules |
| 01/07/2010 | US20100004873 Method of processing biological analysis data and expert system of biological analysis applying this method |
| 01/07/2010 | US20100004578 Apparatus and systems for membraneless separation of fluids |
| 01/07/2010 | US20100004327 Novel Use of Ansamycin Antibiotics And Method of Screening Novel Angiogenesis Inhibitor |
| 01/07/2010 | US20100004306 PIGF-1 Assay and kits and components thereof |
| 01/07/2010 | US20100004281 Viral inhibitors |
| 01/07/2010 | US20100004277 Compounds and methods for modulating protein trafficking |
| 01/07/2010 | US20100004271 Heterocyclic compounds as aganist for the thyroid receptor |
| 01/07/2010 | US20100004180 Agents for the Detection and Modulation of B-Cells and Antibodies |